期刊
CANCERS
卷 14, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/cancers14010033
关键词
vaccines; human papillomavirus; oropharyngeal cancer; head and neck cancers
类别
This article reviews the incidence and pathogenesis of HPV-related cancers worldwide, the development and use of HPV prophylactic vaccines, and the progress and challenges in the development of HPV therapeutic vaccines.
Simple Summary Human papillomavirus (HPV) is recognized as a significant risk factor for head and neck cancers worldwide, and it is the most common cause of oropharyngeal cancers in the United States. Here, we review the incidence and pathogenesis of HPV-related cancers, the development and approval of HPV prophylactic vaccines, and the use and effectiveness of HPV vaccines around the world. Furthermore, we discuss advances in the development of HPV therapeutic vaccines as well as its associated challenges. The rising incidence of oropharyngeal squamous cell cancers (OPSCC) in the United States is largely attributed to HPV. Prophylactic HPV vaccines have demonstrated effectiveness against oral infection of HPV 16 and HPV 18. We review the global epidemiology and biology of HPV-related cancers as well as the development of HPV vaccines and their use worldwide. We also review the various strategies and challenges in development of therapeutic HPV vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据